Ilex Medical Total Assets

Latest as of June 2026: ILA955.92 Million ILA ≈ $2.56 Million USD

Ilex Medical total assets. Based on the latest financial reports, Ilex Medical (ILX) holds total assets worth ILA955.92 Million ILA (≈ $2.56 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Ilex Medical market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Ilex Medical (2008–2025)

Total assets of Ilex Medical from 2008 to 2025. This chart illustrates how Ilex Medical's total assets have evolved over time, based on quarterly financial data. See current stock price of Ilex Medical for real-time trading data and today's change.

Ilex Medical - Asset Composition Analysis

Ilex Medical Total Assets Breakdown (December 2025)

Ilex Medical total assets breakdown as of December 2025. Ilex Medical's total assets of ILA955.92 Million consist of 72.9% current assets and 27.1% non-current assets.

Asset Category Amount (ILA) % of Total Assets
Cash & Equivalents ILA0.00 17.7%
Accounts Receivable ILA266.25 Million 26.8%
Inventory ILA194.21 Million 19.6%
Property, Plant & Equipment ILA0.00 0.0%
Intangible Assets ILA11.95 Million 1.2%
Goodwill ILA7.00 Million 0.7%

Asset Composition Trend (2008–2025)

This chart illustrates how Ilex Medical's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Ilex Medical (ILX) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Ilex Medical's current assets represent 72.9% of total assets in 2025, an increase from 0.0% in 2008.
  • Cash Position: Cash and equivalents constituted 17.7% of total assets in 2025, down from 25.4% in 2008.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2008.
  • Asset Diversification: The largest asset category is accounts receivable at 26.8% of total assets.

Ilex Medical Competitors by Total Assets

Key competitors of Ilex Medical based on total assets are shown below.

Company Country Total Assets
Hanmi Science
KO:008930
Korea ₩1.49 Trillion
Paragon Care Ltd
AU:PGC
Australia AU$1.31 Billion
TELES Informationstechnologien AG
XETRA:TLIK
Germany €4.29 Million
Sigma Healthcare Ltd
AU:SIG
Australia AU$8.74 Billion
Ebos Group Ltd
AU:EBO
Australia AU$8.80 Billion
Mayne Pharma Group Ltd
AU:MYX
Australia AU$1.01 Billion
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Brazil R$5.64 Billion
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
China CN¥240.77 Billion

Ilex Medical - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.07 3.09 2.36
Quick Ratio 2.17 2.39 1.86
Cash Ratio 0.00 0.00 0.00
Working Capital ILA425.35 Million ILA456.84 Million ILA364.43 Million

Ilex Medical - Advanced Valuation Insights

This section examines the relationship between Ilex Medical's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.84
Latest Market Cap to Assets Ratio 0.14
Asset Growth Rate (YoY) -0.1%
Total Assets ILA992.74 Million
Market Capitalization $140.14 Million USD

Valuation Analysis

Below Book Valuation: The market values Ilex Medical's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Ilex Medical's assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Ilex Medical (2008–2025)

The table below shows the annual total assets of Ilex Medical from 2008 to 2025.

Year Total Assets Change
2025-12-31 ILA992.74 Million
≈ $2.66 Million
-0.13%
2024-12-31 ILA994.07 Million
≈ $2.67 Million
-2.17%
2023-12-31 ILA1.02 Billion
≈ $2.72 Million
+13.00%
2022-12-31 ILA899.18 Million
≈ $2.41 Million
+2.76%
2021-12-31 ILA875.07 Million
≈ $2.35 Million
+12.30%
2020-12-31 ILA779.25 Million
≈ $2.09 Million
+33.93%
2019-12-31 ILA581.85 Million
≈ $1.56 Million
+9.09%
2018-12-31 ILA533.38 Million
≈ $1.43 Million
+9.99%
2017-12-31 ILA484.92 Million
≈ $1.30 Million
-0.54%
2016-12-31 ILA487.56 Million
≈ $1.31 Million
+1.24%
2015-12-31 ILA481.60 Million
≈ $1.29 Million
-4.92%
2014-12-31 ILA506.54 Million
≈ $1.36 Million
-5.24%
2013-12-31 ILA534.54 Million
≈ $1.43 Million
-11.01%
2012-12-31 ILA600.69 Million
≈ $1.61 Million
-12.59%
2011-12-31 ILA687.23 Million
≈ $1.84 Million
+258.65%
2010-12-31 ILA191.62 Million
≈ $513.72K
-0.67%
2009-12-31 ILA192.91 Million
≈ $517.19K
+13.39%
2008-12-31 ILA170.14 Million
≈ $456.13K
--

About Ilex Medical

TA:ILX Israel Medical Distribution
Market Cap
$140.14 Million
ILA52.27 Billion ILA
Market Cap Rank
#17724 Global
#223 in Israel
Share Price
ILA4672.00
Change (1 day)
+4.36%
52-Week Range
ILA4303.00 - ILA7080.00
All Time High
ILA15645.73
About

Ilex Medical Ltd engages in the import, marketing, distribution and sale of medical laboratory equipment and various diagnostic products, diagnostic systems, and kits and consumables in Israel, the United States, and internationally. The company also provides laboratory services, as well as is involved in the development, production, marketing and sale of software systems for information manageme… Read more